NSE: MARICO · 6 October 2026
- Marico Limited shares edged higher by 0.53% to close at ₹794.15 on Tuesday, October 6, 2026, building upon its previous close of ₹790.00.
- Marico Limited entered into definitive agreements to acquire an additional 38.18% stake in Satiya Nutraceuticals Private Limited in tranches from its founders and other shareholders. The company completed the current acquisition of a 24.09% stake for a cash consideration of ₹1,012.03 crores on October 5, 2026, raising its aggregate shareholding from 60% to 84.09% on a fully diluted basis. The remaining 14.09% stake is slated for acquisition in July 2027.
- Trading volume was 0.88 times the 20-day average daily volume.
Why is MARICO share price rising on 6 October 2026?
Marico Limited shares edged higher by 0.53% to close at ₹794.15 on Tuesday, October 6, 2026, building upon its previous close of ₹790.00.
The broader market tracked positive momentum as the Nifty advanced 0.98% during the session. Marico's minor gain reflected steady consolidation following a recent 5-day return decline of 2.35% and a 20-day pullback of 1.47%, keeping the equity moving in line with broader consumer goods sentiment.
Market participants continue to digest the company's recent strategic moves, notably the definitive agreement announced on October 5, 2026, to acquire an additional 38.18% stake in Satiya Nutraceuticals Private Limited, which owns the brand Plix. While this corporate development adds fundamental context to Marico's ongoing expansion into wellness segments, today's modest price action reflects routine market positioning rather than a direct reaction to the acquisition.
14.39 lakh shares traded by 6 October 2026 · 03:15 PM IST. This compares with a 20-day average daily volume of 16.44 lakh shares (0.88 times). The five-day average daily volume was 20.58 lakh shares. Separately, the NSE report for 5 October 2026 showed 18.77 lakh shares delivered, representing 55.97% of that day’s traded volume. The same report recorded 96,148 trades.
The stock's modest gain of 0.53% occurred on below-average volume (0.88 times the 20-day average volume with a cash volume of 1,438,994 shares), appearing consistent with a mild technical stabilization following recent short-term pullbacks. While major strategic announcements regarding Satiya Nutraceuticals and Q2 operational updates were disclosed recently, today's price movement reflects routine market participation rather than an immediate reaction to those events.
Latest Company Developments
Marico Limited entered into definitive agreements to acquire an additional 38.18% stake in Satiya Nutraceuticals Private Limited in tranches from its founders and other shareholders. The company completed the current acquisition of a 24.09% stake for a cash consideration of ₹1,012.03 crores on October 5, 2026, raising its aggregate shareholding from 60% to 84.09% on a fully diluted basis. The remaining 14.09% stake is slated for acquisition in July 2027.
This transaction deepens Marico's presence in the fast-growing plant-based nutrition and personal care segments through the Plix brand.
Marico released its operational performance and demand trends for the quarter ended September 30, 2026, reporting resilient domestic demand and double-digit underlying volume growth in the India business. Parachute Coconut Oil accelerated with early teens volume growth, while international business delivered constant currency growth in the teens led by Vietnam, the Middle East, and South Africa. Consolidated revenue is expected to grow in double digits with operating profit projected to rise in the mid-twenties.
The operational update highlights strong core volume momentum and margin tailwinds ahead of the detailed financial results.
The board of directors noted the retirement of Mr. Rajeev Vasudeva as an Independent Director, effective at the end of October 31, 2026, due to his increasing professional commitments. Concurrently, the company announced the appointment of Mr. Bhaskar Bhat as the Chairman of the Nomination and Remuneration Committee effective November 1, 2026.
This board transition ensures continuity in governance and committee leadership.
Please find attached an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please find enclosed an update on the operating performance and demand trends witnessed during the quarter ended September 30, 2026
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 8.43% on 30 June 2026. This compares with 8.63% on 31 March 2026, a change of -0.20 percentage points.
The filing reported 43 MF/UTI holders.
What to Watch Next
- Execution and financial integration of the Satiya Nutraceuticals (Plix) acquisition tranche.
- Detailed un-audited financial results for the quarter ended September 30, 2026.
- Volume participation relative to the 20-day average volume benchmark.
Other Dated Coverage
- Why Marico Shares Rose 1.11% Today: Price & Volume Context | 5 October 2026 — 5 October 2026
- Why Marico Share Price Fell 3.21% Today (Sep 29, 2026) — 29 September 2026
More MARICO news and dated analysis →
Frequently Asked Questions
What is the latest MARICO company news?
Marico Limited entered into definitive agreements to acquire an additional 38.18% stake in Satiya Nutraceuticals Private Limited in tranches from its founders and other shareholders. The company completed the current acquisition of a 24.09% stake for a cash consideration of ₹1,012.03 crores on October 5, 2026, raising its aggregate shareholding from 60% to 84.09% on a fully diluted basis. The remaining 14.09% stake is slated for acquisition in July 2027.
How strong was MARICO’s trading volume?
14.39 lakh shares traded, 0.88 times the 20-day average daily volume. The price and volume data are dated 6 October 2026 · 03:15 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Article by: WittyTrades Research Desk
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.